Atreca, Inc.
DelistedCIK 1532346fmd_17JXYGPRF0CNPJ8VQAH7B18SPYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2023, 22 periods
Latest annual · FY2022
Millions- Net income
- (97)
- Free cash flow
- (82)
Latest quarter · Q3 FY2023
Millions- Net income
- (36)
Atreca, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Net income | -$97.2 million | -$109.3 million | 10-K 2023-03-29 · proof | |
| Cash from operating activities | -$80.7 million | -$60.9 million | 10-K 2023-03-29 · proof | |
| Free cash flow | -$81.6 million | -$96 million | 10-K 2023-03-29 · proof |
- What was Atreca, Inc.'s net income in fiscal 2022?
- Atreca, Inc. reported net income of -$97.2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$109.3 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
- What was Atreca, Inc.'s cash from operating activities in fiscal 2022?
- Atreca, Inc. reported cash from operating activities of -$80.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$60.9 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
- What was Atreca, Inc.'s free cash flow in fiscal 2022?
- Atreca, Inc. reported free cash flow of -$81.6 million for fiscal 2022 (the year ended Dec 31, 2022), against -$96 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1532346&period_type=annual&limit=5"Information only, not investment advice.